[LGND] QoQ Quarter Result on 30-Jun-2023 [#Q2]

Stock
[LGND] Ligand Pharmaceuticals Incorporated
Announcement Date
09-Aug-2023
Financial Year
2023
Quarter
30-Jun-2023 [#Q2]
Profit Trend
QoQ- -94.54%
YoY- 355.87%
Quarter Report
LGND's Result
LGND's Financial Summary
View:
Show?
Quarter Result
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
Revenue 30,978 28,101 32,868 26,366 43,979 50,382 66,088 -39.63%
PBT 113,447 17,097 -15,344 3,171 55,536 24,140 857 2489.70%
Tax 27,308 -1,091 -2,552 881 11,922 38,674 453 1433.59%
NP 86,139 18,188 -12,792 2,290 41,949 -14,534 404 3457.37%
Tax Rate -24.07% 6.38% - -27.78% -21.47% -160.21% -52.86% -
Total Cost -55,161 9,913 45,660 24,076 2,030 64,916 65,684 -
Ratio Analysis
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
NP Margin 278.07 64.72 -38.92 8.69 95.38 -28.85 0.61 5801.09%
Per Share
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
EPS 4.86 1.04 -0.74 0.13 2.46 -0.86 0.02 3781.08%
EPS Diluted 4.75 1.03 -0.74 0.13 2.33 -0.86 0.02 3722.35%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.